Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108303 · ClinicalTrials.gov registry record
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 538
- Enrollment target
NCT00108303: Completed study, sponsored by VA Office of Research and Development.
NCT00108303 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 538 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108303 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 538 participants
- Enrollment target
Study Summary
Schizophrenia has long been known to be an illness with significant evidence for a genetic predisposition. The purpose of this study is to determine the genetic abnormalities that cause childhood and adult onset schizophrenia.
Interventions
- OTHER Diagnostic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 538 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108303
The ClinicalTrials.gov registry entry for NCT00108303 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 538 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic is the first listed.
NCT00108303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108303 about?
NCT00108303 is a clinical study titled "Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes". Schizophrenia has long been known to be an illness with significant evidence for a genetic predisposition. The purpose of this study is to determine the genetic abnormalities that cause childhood and adult onset schizophrenia.
What is the current status of trial NCT00108303?
This trial is currently completed. The enrollment target is 538 participants. The study started on 2004-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00108303?
The interventions under investigation include: Diagnostic (OTHER).
Who is sponsoring clinical trial NCT00108303?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.